<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-12-13" modified="2020-10-07" version="209">
<accession>P78347</accession>
<accession>O14743</accession>
<accession>O15359</accession>
<accession>O43546</accession>
<accession>O43588</accession>
<accession>O43589</accession>
<accession>Q75M85</accession>
<accession>Q75M86</accession>
<accession>Q75M87</accession>
<accession>Q75M88</accession>
<accession>Q86U51</accession>
<accession>Q9BSZ4</accession>
<name>GTF2I_HUMAN</name>
<protein>
<recommendedName>
<fullName>General transcription factor II-I</fullName>
<shortName>GTFII-I</shortName>
<shortName>TFII-I</shortName>
</recommendedName>
<alternativeName>
<fullName>Bruton tyrosine kinase-associated protein 135</fullName>
<shortName>BAP-135</shortName>
<shortName>BTK-associated protein 135</shortName>
</alternativeName>
<alternativeName>
<fullName>SRF-Phox1-interacting protein</fullName>
<shortName>SPIN</shortName>
</alternativeName>
<alternativeName>
<fullName>Williams-Beuren syndrome chromosomal region 6 protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">GTF2I</name>
<name type="synonym">BAP135</name>
<name type="synonym">WBSCR6</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="7091" last="7104">
<title>Cloning of an inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1.</title>
<authorList>
<person name="Roy A.L."/>
<person name="Du H."/>
<person name="Gregor P.D."/>
<person name="Novina C.D."/>
<person name="Martinez E."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="9384587"/>
<dbReference type="DOI" id="10.1093/emboj/16.23.7091"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>PROTEIN SEQUENCE OF 162-171; 366-372; 646-658 AND 940-956</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Genes Dev." volume="11" first="2482" last="2493">
<title>A multifunctional DNA-binding protein that promotes the formation of serum response factor/homeodomain complexes: identity to TFII-I.</title>
<authorList>
<person name="Grueneberg D.A."/>
<person name="Henry R.W."/>
<person name="Brauer A."/>
<person name="Novina C.D."/>
<person name="Cheriyath V."/>
<person name="Roy A.L."/>
<person name="Gilman M."/>
</authorList>
<dbReference type="PubMed" id="9334314"/>
<dbReference type="DOI" id="10.1101/gad.11.19.2482"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>PROTEIN SEQUENCE OF 291-294 AND 316-333</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="604" last="609">
<title>BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement.</title>
<authorList>
<person name="Yang W."/>
<person name="Desiderio S."/>
</authorList>
<dbReference type="PubMed" id="9012831"/>
<dbReference type="DOI" id="10.1073/pnas.94.2.604"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>PROTEIN SEQUENCE OF 144-154; 495-514 AND 681-702</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="Hum. Mol. Genet." volume="7" first="325" last="334">
<title>A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.</title>
<authorList>
<person name="Perez Jurado L.A."/>
<person name="Wang Y.-K."/>
<person name="Peoples R."/>
<person name="Coloma A."/>
<person name="Cruces J."/>
<person name="Francke U."/>
</authorList>
<dbReference type="PubMed" id="9466987"/>
<dbReference type="DOI" id="10.1093/hmg/7.3.325"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="Nature" volume="424" first="157" last="164">
<title>The DNA sequence of human chromosome 7.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Graves T.A."/>
<person name="Pepin K.H."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Maas J."/>
<person name="Jaeger S."/>
<person name="Walker R."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="O'Laughlin M.D."/>
<person name="Schaller M.E."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Cordes M."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Edwards J."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Andrews S."/>
<person name="Isak A."/>
<person name="Vanbrunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Lamar B."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Bielicki L."/>
<person name="Scott K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Harris A."/>
<person name="Strong C.M."/>
<person name="Hou S."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Leonard S."/>
<person name="Rohlfing T."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Abbott A."/>
<person name="Minx P."/>
<person name="Maupin R."/>
<person name="Strowmatt C."/>
<person name="Latreille P."/>
<person name="Miller N."/>
<person name="Johnson D."/>
<person name="Murray J."/>
<person name="Woessner J.P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Schultz B.R."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Nelson J.O."/>
<person name="Berkowicz N."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Bedell J.A."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Chissoe S.L."/>
<person name="Marra M.A."/>
<person name="Raymond C."/>
<person name="Haugen E."/>
<person name="Gillett W."/>
<person name="Zhou Y."/>
<person name="James R."/>
<person name="Phelps K."/>
<person name="Iadanoto S."/>
<person name="Bubb K."/>
<person name="Simms E."/>
<person name="Levy R."/>
<person name="Clendenning J."/>
<person name="Kaul R."/>
<person name="Kent W.J."/>
<person name="Furey T.S."/>
<person name="Baertsch R.A."/>
<person name="Brent M.R."/>
<person name="Keibler E."/>
<person name="Flicek P."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Bailey J.A."/>
<person name="Portnoy M.E."/>
<person name="Torrents D."/>
<person name="Chinwalla A.T."/>
<person name="Gish W.R."/>
<person name="Eddy S.R."/>
<person name="McPherson J.D."/>
<person name="Olson M.V."/>
<person name="Eichler E.E."/>
<person name="Green E.D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="12853948"/>
<dbReference type="DOI" id="10.1038/nature01782"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Lymph</tissue>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2007-07" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Murray L."/>
<person name="Brunton V.G."/>
<person name="Frame M.C."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-20; 131-140; 178-185; 364-371; 444-456; 495-514; 540-555; 574-594; 620-628; 870-878; 917-927 AND 929-937</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Colon adenocarcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="5014" last="5024">
<title>Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.</title>
<authorList>
<person name="Novina C.D."/>
<person name="Kumar S."/>
<person name="Bajpai U."/>
<person name="Cheriyath V."/>
<person name="Zhang K."/>
<person name="Pillai S."/>
<person name="Wortis H.H."/>
<person name="Roy A.L."/>
</authorList>
<dbReference type="PubMed" id="10373551"/>
<dbReference type="DOI" id="10.1128/mcb.19.7.5014"/>
</citation>
<scope>INTERACTION WITH BTK</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="27806" last="27815">
<title>Identification of phosphorylation sites for Bruton's tyrosine kinase within the transcriptional regulator BAP/TFII-I.</title>
<authorList>
<person name="Egloff A.M."/>
<person name="Desiderio S."/>
</authorList>
<dbReference type="PubMed" id="11373296"/>
<dbReference type="DOI" id="10.1074/jbc.m103692200"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-248; TYR-398 AND TYR-503</scope>
<scope>INTERACTION WITH BTK</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF TYR-248; TYR-398; TYR-460 AND TYR-503</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="32003" last="32014">
<title>cGMP-dependent protein kinase I beta physically and functionally interacts with the transcriptional regulator TFII-I.</title>
<authorList>
<person name="Casteel D.E."/>
<person name="Zhuang S."/>
<person name="Gudi T."/>
<person name="Tang J."/>
<person name="Vuica M."/>
<person name="Desiderio S."/>
<person name="Pilz R.B."/>
</authorList>
<dbReference type="PubMed" id="12082086"/>
<dbReference type="DOI" id="10.1074/jbc.m112332200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-412 AND SER-784 BY PRKG1</scope>
<scope>INTERACTION WITH PRKG1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="5004" last="5012">
<title>Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.</title>
<authorList>
<person name="Gocke C.B."/>
<person name="Yu H."/>
<person name="Kang J."/>
</authorList>
<dbReference type="PubMed" id="15561718"/>
<dbReference type="DOI" id="10.1074/jbc.m411718200"/>
</citation>
<scope>SUMOYLATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="4758" last="4768">
<title>Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.</title>
<authorList>
<person name="Rajaiya J."/>
<person name="Nixon J.C."/>
<person name="Ayers N."/>
<person name="Desgranges Z.P."/>
<person name="Roy A.L."/>
<person name="Webb C.F."/>
</authorList>
<dbReference type="PubMed" id="16738337"/>
<dbReference type="DOI" id="10.1128/mcb.02009-05"/>
</citation>
<scope>INTERACTION WITH ARID3A AND BTK</scope>
<scope>PHOSPHORYLATION AT TYR-248</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103; SER-207; SER-210 AND THR-558</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103 AND THR-558</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103; THR-558 AND SER-823</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-668</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-103; SER-210; SER-214; SER-412; SER-517; THR-558; SER-674; SER-722 AND SER-784</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103 AND SER-823</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-278 (ISOFORM 2)</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298 (ISOFORM 4)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-94; LYS-221; LYS-343; LYS-353; LYS-456; LYS-488; LYS-561; LYS-715 AND LYS-991</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-221 AND LYS-991</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-94; LYS-130; LYS-221; LYS-326; LYS-343; LYS-353; LYS-456; LYS-488; LYS-561; LYS-660; LYS-664; LYS-715 AND LYS-991</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-86; LYS-221; LYS-456; LYS-488; LYS-561; LYS-664; LYS-816 AND LYS-991</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-35; LYS-86; LYS-92; LYS-94; LYS-130; LYS-140; LYS-185; LYS-219; LYS-221; LYS-326; LYS-343; LYS-353; LYS-380; LYS-435; LYS-450; LYS-456; LYS-488; LYS-494; LYS-526; LYS-561; LYS-660; LYS-664; LYS-670; LYS-680; LYS-715; LYS-816; LYS-827; LYS-861; LYS-864; LYS-879; LYS-891 AND LYS-991</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="submission" date="2007-08" db="PDB data bank">
<title>Solution structure of RSGI RUH-052, a GTF2I domain in human.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 102-197 AND 361-554</scope>
</reference>
<comment type="function">
<text evidence="23 24 27">Interacts with the basal transcription machinery by coordinating the formation of a multiprotein complex at the C-FOS promoter, and linking specific signal responsive activator complexes. Promotes the formation of stable high-order complexes of SRF and PHOX1 and interacts cooperatively with PHOX1 to promote serum-inducible transcription of a reporter gene deriven by the C-FOS serum response element (SRE). Acts as a coregulator for USF1 by binding independently two promoter elements, a pyrimidine-rich initiator (Inr) and an upstream E-box. Required for the formation of functional ARID3A DNA-binding complexes and for activation of immunoglobulin heavy-chain transcription upon B-lymphocyte activation.</text>
</comment>
<comment type="subunit">
<text evidence="23 24 25 27 35">Homodimer (Potential). Interacts with SRF and PHOX1. Binds a pyrimidine-rich initiator (Inr) and a recognition site (E-box) for upstream stimulatory factor 1 (USF1). Associates with the PH domain of Bruton's tyrosine kinase (BTK). May be a component of a BHC histone deacetylase complex that contains HDAC1, HDAC2, HMG20B/BRAF35, KDM1A, RCOR1/CoREST, PHF21A/BHC80, ZMYM2, ZNF217, ZMYM3, GSE1 and GTF2I. Interacts with BTK and ARID3A. Interacts with isoform beta of PRKG1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-359622">
<id>P78347</id>
</interactant>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-359622">
<id>P78347</id>
</interactant>
<interactant intactId="EBI-624835">
<id>Q06187</id>
<label>BTK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12033200">
<id>P78347-2</id>
</interactant>
<interactant intactId="EBI-11978055">
<id>Q10567-3</id>
<label>AP1B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12033200">
<id>P78347-2</id>
</interactant>
<interactant intactId="EBI-11529439">
<id>P63010-2</id>
<label>AP2B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12033200">
<id>P78347-2</id>
</interactant>
<interactant intactId="EBI-1188472">
<id>P78358</id>
<label>CTAG1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12033200">
<id>P78347-2</id>
</interactant>
<interactant intactId="EBI-744973">
<id>Q9C005</id>
<label>DPY30</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12033200">
<id>P78347-2</id>
</interactant>
<interactant intactId="EBI-2130429">
<id>Q9BYV2</id>
<label>TRIM54</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="23">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="22 23">Nucleus</location>
</subcellularLocation>
<text>Colocalizes with BTK in the cytoplasm.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P78347-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P78347-2</id>
<name>2</name>
<sequence type="described" ref="VSP_003867 VSP_003868"/>
</isoform>
<isoform>
<id>P78347-3</id>
<name>3</name>
<sequence type="described" ref="VSP_003867"/>
</isoform>
<isoform>
<id>P78347-4</id>
<name>4</name>
<sequence type="described" ref="VSP_003868"/>
</isoform>
<isoform>
<id>P78347-5</id>
<name>5</name>
<sequence type="described" ref="VSP_003867 VSP_055195 VSP_055196"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Ubiquitous. Isoform 1 is strongly expressed in fetal brain, weakly in adult brain, muscle, and lymphoblasts and is almost undetectable in other adult tissues, while the other isoforms are equally expressed in all adult tissues.</text>
</comment>
<comment type="PTM">
<text evidence="23 24 25 27">Transiently phosphorylated on tyrosine residues by BTK in response to B-cell receptor stimulation. Phosphorylation on Tyr-248 and Tyr-398, and perhaps, on Tyr-503 contributes to BTK-mediated transcriptional activation.</text>
</comment>
<comment type="PTM">
<text evidence="26">Sumoylated.</text>
</comment>
<comment type="disease">
<text>GTF2I is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region. Haploinsufficiency of GTF2I may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in the disease.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the TFII-I family.</text>
</comment>
<dbReference type="EMBL" id="AF015553">
<property type="protein sequence ID" value="AAB70791.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y14946">
<property type="protein sequence ID" value="CAA75163.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U77948">
<property type="protein sequence ID" value="AAB48826.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035737">
<property type="protein sequence ID" value="AAC08312.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF038967">
<property type="protein sequence ID" value="AAC08313.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF038968">
<property type="protein sequence ID" value="AAC08314.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF038969">
<property type="protein sequence ID" value="AAC08315.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007450">
<property type="protein sequence ID" value="AAP36118.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005231">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC083884">
<property type="protein sequence ID" value="AAS07460.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC083884">
<property type="protein sequence ID" value="AAS07461.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC083884">
<property type="protein sequence ID" value="AAS07462.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC083884">
<property type="protein sequence ID" value="AAS07463.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC083884">
<property type="protein sequence ID" value="AAS07464.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004883">
<property type="protein sequence ID" value="AAL93085.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471200">
<property type="protein sequence ID" value="EAW69598.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004472">
<property type="protein sequence ID" value="AAH04472.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC070484">
<property type="protein sequence ID" value="AAH70484.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47614.1">
<molecule id="P78347-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5573.1">
<molecule id="P78347-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5574.1">
<molecule id="P78347-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5575.1">
<molecule id="P78347-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS64680.1">
<molecule id="P78347-5"/>
</dbReference>
<dbReference type="PIR" id="T03829">
<property type="entry name" value="T03829"/>
</dbReference>
<dbReference type="PIR" id="T09492">
<property type="entry name" value="T09492"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001157108.1">
<property type="nucleotide sequence ID" value="NM_001163636.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001267729.1">
<molecule id="P78347-5"/>
<property type="nucleotide sequence ID" value="NM_001280800.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001509.3">
<molecule id="P78347-2"/>
<property type="nucleotide sequence ID" value="NM_001518.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_127492.1">
<molecule id="P78347-1"/>
<property type="nucleotide sequence ID" value="NM_032999.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_127493.1">
<molecule id="P78347-3"/>
<property type="nucleotide sequence ID" value="NM_033000.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_127494.1">
<molecule id="P78347-4"/>
<property type="nucleotide sequence ID" value="NM_033001.3"/>
</dbReference>
<dbReference type="PDB" id="2D9B">
<property type="method" value="NMR"/>
<property type="chains" value="A=102-197"/>
</dbReference>
<dbReference type="PDB" id="2DN4">
<property type="method" value="NMR"/>
<property type="chains" value="A=361-446"/>
</dbReference>
<dbReference type="PDB" id="2ED2">
<property type="method" value="NMR"/>
<property type="chains" value="A=466-551"/>
</dbReference>
<dbReference type="PDB" id="2EJE">
<property type="method" value="NMR"/>
<property type="chains" value="A=854-954"/>
</dbReference>
<dbReference type="PDBsum" id="2D9B"/>
<dbReference type="PDBsum" id="2DN4"/>
<dbReference type="PDBsum" id="2ED2"/>
<dbReference type="PDBsum" id="2EJE"/>
<dbReference type="SMR" id="P78347"/>
<dbReference type="BioGRID" id="109224">
<property type="interactions" value="179"/>
</dbReference>
<dbReference type="CORUM" id="P78347"/>
<dbReference type="DIP" id="DIP-24252N"/>
<dbReference type="IntAct" id="P78347">
<property type="interactions" value="73"/>
</dbReference>
<dbReference type="MINT" id="P78347"/>
<dbReference type="STRING" id="9606.ENSP00000460070"/>
<dbReference type="iPTMnet" id="P78347"/>
<dbReference type="MetOSite" id="P78347"/>
<dbReference type="PhosphoSitePlus" id="P78347"/>
<dbReference type="SwissPalm" id="P78347"/>
<dbReference type="BioMuta" id="GTF2I"/>
<dbReference type="DMDM" id="17865459"/>
<dbReference type="CPTAC" id="CPTAC-1349"/>
<dbReference type="EPD" id="P78347"/>
<dbReference type="jPOST" id="P78347"/>
<dbReference type="MassIVE" id="P78347"/>
<dbReference type="PaxDb" id="P78347"/>
<dbReference type="PeptideAtlas" id="P78347"/>
<dbReference type="PRIDE" id="P78347"/>
<dbReference type="ProteomicsDB" id="57578">
<molecule id="P78347-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57579">
<molecule id="P78347-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57580">
<molecule id="P78347-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57581">
<molecule id="P78347-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="69770"/>
<dbReference type="Antibodypedia" id="73029">
<property type="antibodies" value="406 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="2969"/>
<dbReference type="Ensembl" id="ENST00000443166">
<molecule id="P78347-5"/>
<property type="protein sequence ID" value="ENSP00000404240"/>
<property type="gene ID" value="ENSG00000263001"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000573035">
<molecule id="P78347-1"/>
<property type="protein sequence ID" value="ENSP00000460070"/>
<property type="gene ID" value="ENSG00000263001"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000614986">
<molecule id="P78347-3"/>
<property type="protein sequence ID" value="ENSP00000484526"/>
<property type="gene ID" value="ENSG00000263001"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000620879">
<molecule id="P78347-2"/>
<property type="protein sequence ID" value="ENSP00000477837"/>
<property type="gene ID" value="ENSG00000263001"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000621734">
<molecule id="P78347-4"/>
<property type="protein sequence ID" value="ENSP00000482476"/>
<property type="gene ID" value="ENSG00000263001"/>
</dbReference>
<dbReference type="GeneID" id="2969"/>
<dbReference type="KEGG" id="hsa:2969"/>
<dbReference type="UCSC" id="uc003uat.5">
<molecule id="P78347-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2969"/>
<dbReference type="DisGeNET" id="2969"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000263001.5"/>
<dbReference type="GeneCards" id="GTF2I"/>
<dbReference type="HGNC" id="HGNC:4659">
<property type="gene designation" value="GTF2I"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000263001">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="GTF2I"/>
<dbReference type="MIM" id="601679">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P78347"/>
<dbReference type="OpenTargets" id="ENSG00000263001"/>
<dbReference type="Orphanet" id="904">
<property type="disease" value="Williams syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29045"/>
<dbReference type="eggNOG" id="ENOG502QWD0">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160349"/>
<dbReference type="HOGENOM" id="CLU_011773_0_0_1"/>
<dbReference type="InParanoid" id="P78347"/>
<dbReference type="KO" id="K03121"/>
<dbReference type="OMA" id="VEVTIEX"/>
<dbReference type="PhylomeDB" id="P78347"/>
<dbReference type="TreeFam" id="TF352524"/>
<dbReference type="PathwayCommons" id="P78347"/>
<dbReference type="SIGNOR" id="P78347"/>
<dbReference type="BioGRID-ORCS" id="2969">
<property type="hits" value="63 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="GTF2I">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P78347"/>
<dbReference type="GeneWiki" id="GTF2I"/>
<dbReference type="GenomeRNAi" id="2969"/>
<dbReference type="Pharos" id="P78347">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P78347"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="RNAct" id="P78347">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000263001">
<property type="expression patterns" value="Expressed in corpus callosum and 197 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P78347">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P78347">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001102">
<property type="term" value="F:RNA polymerase II activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016525">
<property type="term" value="P:negative regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051481">
<property type="term" value="P:negative regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0100026">
<property type="term" value="P:positive regulation of DNA repair by transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.1460.10">
<property type="match status" value="6"/>
</dbReference>
<dbReference type="InterPro" id="IPR004212">
<property type="entry name" value="GTF2I"/>
</dbReference>
<dbReference type="InterPro" id="IPR036647">
<property type="entry name" value="GTF2I-like_rpt_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR016659">
<property type="entry name" value="TF_II-I"/>
</dbReference>
<dbReference type="Pfam" id="PF02946">
<property type="entry name" value="GTF2I"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF016441">
<property type="entry name" value="TF_II-I"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF117773">
<property type="entry name" value="SSF117773"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="PROSITE" id="PS51139">
<property type="entry name" value="GTF2I"/>
<property type="match status" value="6"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0856">Williams-Beuren syndrome</keyword>
<feature type="initiator methionine" description="Removed" evidence="7 11 12 28">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="General transcription factor II-I" id="PRO_0000083872">
<location>
<begin position="2"/>
<end position="998"/>
</location>
</feature>
<feature type="repeat" description="GTF2I-like 1">
<location>
<begin position="103"/>
<end position="197"/>
</location>
</feature>
<feature type="repeat" description="GTF2I-like 2">
<location>
<begin position="352"/>
<end position="446"/>
</location>
</feature>
<feature type="repeat" description="GTF2I-like 3">
<location>
<begin position="457"/>
<end position="551"/>
</location>
</feature>
<feature type="repeat" description="GTF2I-like 4">
<location>
<begin position="562"/>
<end position="656"/>
</location>
</feature>
<feature type="repeat" description="GTF2I-like 5">
<location>
<begin position="724"/>
<end position="818"/>
</location>
</feature>
<feature type="repeat" description="GTF2I-like 6">
<location>
<begin position="859"/>
<end position="953"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="21">
<location>
<begin position="320"/>
<end position="327"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Asn">
<location>
<begin position="692"/>
<end position="695"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="7 11 12 28">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="19"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8 9 13 14">
<location>
<position position="103"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="20">
<location>
<position position="130"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="207"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 13">
<location>
<position position="210"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by BTK" evidence="24 27">
<location>
<position position="248"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="20">
<location>
<position position="353"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by BTK" evidence="24">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKG/PRKG1" evidence="13 25">
<location>
<position position="412"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="20">
<location>
<position position="450"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by BTK" evidence="24">
<location>
<position position="503"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="517"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="20">
<location>
<position position="556"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6 8 9 13">
<location>
<position position="558"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="668"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="674"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="20">
<location>
<position position="715"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="722"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKG/PRKG1" evidence="13 25">
<location>
<position position="784"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 14">
<location>
<position position="823"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="35"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17 19">
<location>
<position position="86"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="92"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 18 19">
<location>
<position position="94"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="18 19">
<location>
<position position="130"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="140"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="185"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="219"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="15">
<location>
<position position="221"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="15 16 17 18 19">
<location>
<position position="221"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18 19">
<location>
<position position="326"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 18 19">
<location>
<position position="343"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="16 18 19">
<location>
<position position="353"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="380"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="435"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="19">
<location>
<position position="450"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 17 18 19">
<location>
<position position="456"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 17 18 19">
<location>
<position position="488"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="494"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="526"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 17 18 19">
<location>
<position position="561"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18 19">
<location>
<position position="660"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17 18 19">
<location>
<position position="664"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="670"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="680"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="16 18 19">
<location>
<position position="715"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17 19">
<location>
<position position="816"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="827"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="861"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="864"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="879"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="891"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="15">
<location>
<position position="991"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="15 16 17 18 19">
<location>
<position position="991"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 3 and isoform 5." id="VSP_003867" evidence="29 30 31 32 33 34">
<location>
<begin position="255"/>
<end position="274"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_003868" evidence="29 30 31 32 33">
<location>
<begin position="294"/>
<end position="314"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_055195" evidence="29 34">
<original>D</original>
<variation>G</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_055196" evidence="29 34">
<location>
<begin position="295"/>
<end position="998"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1057896." id="VAR_051026">
<original>L</original>
<variation>V</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes BTK-mediated transcriptional activation. Abolishes BTK-mediated phosphorylation and impairs BTK-mediated transcriptional activation; when associated with F-398 and F-503." evidence="24">
<original>Y</original>
<variation>F</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes BTK-mediated transcriptional activation. Abolishes BTK-mediated phosphorylation and impairs BTK-mediated transcriptional activation; when associated with F-248 and F-503." evidence="24">
<original>Y</original>
<variation>F</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change on BTK-mediated transcriptional activation." evidence="24">
<original>Y</original>
<variation>F</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs BTK-mediated transcriptional activation. Abolishes BTK-mediated phosphorylation and impairs BTK-mediated transcriptional activation; when associated with F-248 and F-398." evidence="24">
<original>Y</original>
<variation>F</variation>
<location>
<position position="503"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAB48826." ref="3" evidence="35">
<original>L</original>
<variation>G</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAB48826." ref="3" evidence="35">
<original>A</original>
<variation>G</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB70791." ref="1" evidence="35">
<original>A</original>
<variation>R</variation>
<location>
<position position="481"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAB48826." ref="3" evidence="35">
<original>R</original>
<variation>H</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAB48826." ref="3" evidence="35">
<original>E</original>
<variation>K</variation>
<location>
<position position="960"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="106"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="138"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="146"/>
<end position="152"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="167"/>
<end position="175"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="176"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="181"/>
<end position="185"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="361"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="387"/>
<end position="392"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="393"/>
<end position="396"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="397"/>
<end position="401"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="411"/>
<end position="413"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="416"/>
<end position="424"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="426"/>
<end position="428"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="430"/>
<end position="434"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="437"/>
<end position="439"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="466"/>
<end position="482"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="492"/>
<end position="497"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="499"/>
<end position="501"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="502"/>
<end position="506"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="516"/>
<end position="518"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="521"/>
<end position="529"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="530"/>
<end position="533"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="535"/>
<end position="539"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="541"/>
<end position="544"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="856"/>
<end position="858"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="861"/>
<end position="883"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="894"/>
<end position="899"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="901"/>
<end position="907"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="918"/>
<end position="920"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="923"/>
<end position="931"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="932"/>
<end position="935"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="937"/>
<end position="942"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location sequence="P78347-2">
<position position="278"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location sequence="P78347-4">
<position position="298"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2D9B"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DN4"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ED2"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2EJE"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9ESZ8"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255"/>
<evidence key="22" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00484"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10373551"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11373296"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12082086"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15561718"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16738337"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9012831"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9334314"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9384587"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9466987"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source ref="5"/>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<sequence length="998" mass="112416" checksum="4CFA2C19002869B9" modified="2001-12-13" version="2">MAQVAMSTLPVEDEESSESRMVVTFLMSALESMCKELAKSKAEVACIAVYETDVFVVGTERGRAFVNTRKDFQKDFVKYCVEEEEKAAEMHKMKSTTQANRMSVDAVEIETLRKTVEDYFCFCYGKALGKSTVVPVPYEKMLRDQSAVVVQGLPEGVAFKHPENYDLATLKWILENKAGISFIIKRPFLEPKKHVGGRVMVTDADRSILSPGGSCGPIKVKTEPTEDSGISLEMAAVTVKEESEDPDYYQYNIQAGPSETDDVDEKQPLSKPLQGSHHSSEGNEGTEMEVPAEDSTQHVPSETSEDPEVEVTIEDDDYSPPSKRPKANELPQPPVPEPANAGKRKVREFNFEKWNARITDLRKQVEELFERKYAQAIKAKGPVTIPYPLFQSHVEDLYVEGLPEGIPFRRPSTYGIPRLERILLAKERIRFVIKKHELLNSTREDLQLDKPASGVKEEWYARITKLRKMVDQLFCKKFAEALGSTEAKAVPYQKFEAHPNDLYVEGLPENIPFRSPSWYGIPRLEKIIQVGNRIKFVIKRPELLTHSTTEVTQPRTNTPVKEDWNVRITKLRKQVEEIFNLKFAQALGLTEAVKVPYPVFESNPEFLYVEGLPEGIPFRSPTWFGIPRLERIVRGSNKIKFVVKKPELVISYLPPGMASKINTKALQSPKRPRSPGSNSKVPEIEVTVEGPNNNNPQTSAVRTPTQTNGSNVPFKPRGREFSFEAWNAKITDLKQKVENLFNEKCGEALGLKQAVKVPFALFESFPEDFYVEGLPEGVPFRRPSTFGIPRLEKILRNKAKIKFIIKKPEMFETAIKESTSSKSPPRKINSSPNVNTTASGVEDLNIIQVTIPDDDNERLSKVEKARQLREQVNDLFSRKFGEAIGMGFPVKVPYRKITINPGCVVVDGMPPGVSFKAPSYLEISSMRRILDSAEFIKFTVIRPFPGLVINNQLVDQSESEGPVIQESAEPSQLEVPATEEIKETDGSSQIKQEPDPTW</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

